BridgeMD
Compares treatment options for Ventral Hernia
Official title oPen Versus RobotIc retrOmuscular Repair in Medium to Large Ventral Hernias
ClinicalTrials.gov ID: NCT06364306
What this study is testing
- What it's testing
- This study investigates on the effect of two different operative techniques to treat large abdominal wall defects. The goal of this clinical trial is to learn if the minimally-invasive, robotically-assisted ventral hernia repair (RVHR) leads to a better outcome than the open ventral hernia repair (OVHR).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient age \>18 years
- Informed consent obtained
- Transverse diameter of ventral hernia \>4cm - 15cm
- Eligible to open and minimally-invasive surgery according to preoperative anaesthetic assessment
You likely can't join if
- precedent hernia treatment with mesh placement in the retromuscular space
- precedent anterior or posterior component separation or transversus abdominis release (TAR)
- active wound infection
- current cancer diagnosis
- presence of ileostomy, colostomy or ileal conduit
- liver disease defined by the presence of ascites
See the full eligibility criteria
- Patient age \>18 years
- Informed consent obtained
- Transverse diameter of ventral hernia \>4cm - 15cm
- Eligible to open and minimally-invasive surgery according to preoperative anaesthetic assessment
- precedent hernia treatment with mesh placement in the retromuscular space
- precedent anterior or posterior component separation or transversus abdominis release (TAR)
- active wound infection
- current cancer diagnosis
- presence of ileostomy, colostomy or ileal conduit
- liver disease defined by the presence of ascites
- end-stage renal disease requiring dialysis
- need of an emergency surgery
- pregnancy Criteria for participating surgeons Each participating surgeon has performed 20 or more OVHR and RVHR.
The study team makes the final eligibility decision.
Where it's taking place
- Kempten (Allgäu), Bavaria, Germany
- Basel, Canton of Basel-City, Switzerland
- Visp, Valais, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kempten (Allgäu), Bavaria, Germany; Basel, Canton of Basel-City, Switzerland; Visp, Valais, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.